0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query global markets direct transforming growth factor beta 2 bsc1 cell growth inhibitor cetermin 0.Your search for "" gave back 1533059 results.
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
August 2020
Price: USD 2,000.00
The global Beta-lactam and Beta-lactamase Inhibitors market size was valued at US$ 27710 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
Transforming Growth Factor Beta 3 (TGFB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
Transforming Growth Factor Beta (TGFb) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary...
Catalog:
Global Markets Direct
May 2022
Price: USD 3,500.00
β-Lactams are the most widely used class of antibiotics. Since the discovery of benzylpenicillin in the 1920s, thousands of new penicillin...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Beta-lactam and Beta-lactamase Inhibitors market size was valued at USD 29150 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
β-Lactams are the most widely used class of antibiotics. Since the discovery of benzylpenicillin in the 1920s, thousands of new penicillin...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Heparanase - Drugs In Development, 2021 Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 Summary According to the recently published report 'Gamma Secretase - Drugs In...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Gamma Secretase - Pipeline Review, H2 2020 Summary According to the recently published report 'Gamma Secretase - Pipeline Review, H2 2020...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,500.00
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
20s Proteasome - Pipeline Review, H2 2020 Summary According to the recently published report '20s Proteasome - Pipeline Review, H2 2020';...
Catalog:
Global Markets Direct
November 2020
Price: USD 3,500.00
20s Proteasome - Pipeline Review, H2 2019 Summary 20s Proteasome - 20S proteasome is the catalytic core of the 26S proteasome, the central protease...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
